Zomedica (ZOM) and Elanco (ELAN) are companies within the pet healthcare industry. While one is in the development stage the other is an established player. The pet industry all over the world continues to expand making the two companies enticing bets for 2021 and beyond but which one is a better buy now?.Several industries have benefited from the COVID-19 pandemic as people were confined to their homes and entertainment options were limited. Companies part of the e-commerce, streaming, gaming, and streaming vertical saw a massive uptick in consumer demand.
Another space that significantly benefited from the coronavirus lockdown was the pet industry. More than 11 million U.S. households were estimated to have gotten a new pet during the pandemic. This trend acted as a secular driver for pet healthcare companies.
Here, we take a look at two companies part of the pet healthcare industry, Zomedica (ZOM) and Elanco (ELAN), to analyze which is a better stock right now.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.